WASHINGTON The Food and Drug Administration has granted approval to Aurobindo Pharma to manufacture and market losartan potassium tablets in 25 mg, 50 mg and 100 mg strengths, according to FDA ...

Aurobindo Pharma USA has recalled 80 lots ... The company initially recalled two lots of losartan 100-mg tablets on December 20, 2018. The expanded recall to the consumer level involves losartan ...

Aurobindo customers with questions or who want to report problems with the medication can call 866-850-2876 and take Option No. 2 or email pvg@aurobindousa.com. For a full list of all Losartan ...

Losartan 50 mg 31722-701-30, 31722-701-90, 31722-70-10; and Losartan 100 mg 31722-702-30, 31722-702-90, and 31722-702-10. For more information on the recalled products, visit the FDA's website here.

The company has received the tentative approval to manufacture and market Losartan Potassium tablets in the strength of 25 mg, 50 mg and 100 mg from USFDA, Aurobindo Phrama said in a filing to the ...

Three drug companies recalled 126 lots of the blood pressure drugs losartan and valsartan this ... Camber says the recalled 25 mg, 50 mg and 100 mg tablets were distributed nationally to ...

Losartan 50 mg 31722-701-30, 31722-701-90, 31722-70-10; and Losartan 100 mg 31722-702-30, 31722-702-90, and 31722-702-10. The affected Losartan tablets have expiration dates that run from ...

Losartan tablets in 25, 50 and 100 mg doses are being recalled by Camber. They were distributed nationwide. Consumers should speak with their doctor to discuss the recall before they stop taking ...

The discovery has led to a global recall of hundreds of lots and millions of bottles of the commonly prescribed blood pressure meds valsartan, losartan and Irbesartan. Aurobindo blames the ...